Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stock Psychology

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Aug 22, 2023 12:39pm

341 Views

Post# 35600067

Stock Psychology

Funny to know when you have fallen in love with a stock.

If it goes down, you look away and understand perfectly that it is a temporary aboration from the norm.

Ifi it goes up, you celebrate and know that "this is the time" and it will never again be so low.

So, is it real this time?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec